VILDAGLIPTIN
Sitagliptin inhibits dipeptidyl peptidase IV (DPP-IV), Vildagliptin is an antidiabetic medicine used alone or in combination with other medicines to treat type 2 diabetes in adult patients.Type 2 diabetes mellitus
Oral; 50mg to 100mg per day along with metformin or sulfonylurea.
Hypersensitivity
Renal impairement
Hypoglycaemia, delayed gastric emptying, nausea and vomiting, flu-like symptoms, headache and dizziness may occur, stevens-johnson syndrome.
Risk of hypoglycemia with other anti-diabetic drug.